Skip to content
About
Our Mission
The challenge
Deliberables
Structure
Core Group
Management Committee
Working Groups
WG1: Tools for NRF2 research
WG2: Pharmacological regulation and drugs
WG3: Translational medicine
WG4. Economic Exploitation
WG5: Outreach and dissemination
Events
Scientific Meetings
Webinars
Training Schools
Open Days
Podcasts
News
Newsletters
Special Issues
Other news
Projects
Dissemination
Co-authored Action publications
Collaborative publications
Open Days
About
Our Mission
The challenge
Deliberables
Structure
Core Group
Management Committee
Working Groups
WG1: Tools for NRF2 research
WG2: Pharmacological regulation and drugs
WG3: Translational medicine
WG4. Economic Exploitation
WG5: Outreach and dissemination
Events
Scientific Meetings
Webinars
Training Schools
Open Days
Podcasts
News
Newsletters
Special Issues
Other news
Projects
Dissemination
Co-authored Action publications
Collaborative publications
Open Days
Intranet
The current status and future prospects for therapeutic targeting of KEAP1-NRF2 and β-TrCP-NRF2 interactions in cancer chemoresistance
01/11/2022
Srivastava R, Fernández-Ginés R, Encinar JA, Cuadrado A, Wells G
By:Srivastava R, Fernández-Ginés R, Encinar JA, Cuadrado A, Wells G
Go to publication
